Redicare Nasal and Sinus Decongestant

Manufacturer
Redicare LLC
Effective date
2025-03-04
Label type
HUMAN OTC DRUG LABEL
Version
2
Source
full-release
Hydrated at
2026-06-01 00:56:38

Label at a glance#

ProductRedicare Nasal and Sinus Decongestant
Active ingredientPHENYLEPHRINE HYDROCHLORIDE
Label structure10 sections

Indications and uses

■ temporarily relieves sinus congestion and pressure ■ temporarily relieves nasal congestion due to the common cold, hay fever or other upper respiratory allergies

Dosage and administration

Adults and children 12 years and over: ■ 1 tablet every 4 hours ■ do not take more than 6 tablets in 24 hours Children under 12 years: ask a doctor

Storage and handling

■ store at room temperature 20°– 25°C (68°– 77°F) ■ do not use if carton or blister unit is opened or broken [for blister]

Label contents#

Full prescribing information#

Active Ingredient (in each tablet)

OTC - ACTIVE INGREDIENT SECTION

Phenylephrine HCl 10mg

Purpose

OTC - PURPOSE SECTION

Nasal decongestant

Uses:

INDICATIONS & USAGE SECTION

■ temporarily relieves sinus congestion and pressure ■ temporarily relieves nasal congestion due to the common cold, hay fever or other upper respiratory allergies

Warnings:

WARNINGS SECTION

Do not use if

OTC - DO NOT USE SECTION

you are now taking a prescription monoamine oxidase inhibitor (MAOI) (certain drugs for depression, psychiatric or emotional conditions, or Parkinson's disease), or for 2 weeks after stopping the MAOI drug. If you do not know if your prescription drug contains an MAOI, ask a doctor or pharmacist before taking this product.

Ask a doctor before use if you have

OTC - ASK DOCTOR SECTION

■ heart disease ■ high blood pressure ■ thyroid disease ■ diabetes ■ trouble urinating due to an enlarged prostate gland

When using this product

OTC - WHEN USING SECTION

do not exceed recommended dose

Stop use and ask a doctor if

OTC - STOP USE SECTION

■ nervousness, dizziness, or sleeplessness occur ■ symptoms do not improve within 7 days or occur with a fever

If pregnant or breast-feeding,

OTC - PREGNANCY OR BREAST FEEDING SECTION

ask a health professional before use.

Keep out of reach of children.

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

In case of overdose, get medical help or contact a Poison Control Center (1-800-222-1222) right away.

Directions:

DOSAGE & ADMINISTRATION SECTION

Adults and children 12 years and over: ■ 1 tablet every 4 hours ■ do not take more than 6 tablets in 24 hours
Children under 12 years: ask a doctor

Other Information:

STORAGE AND HANDLING SECTION

■ store at room temperature 20°– 25°C (68°– 77°F)
■ do not use if carton or blister unit is opened or broken [for blister]

Inactive Ingredients:

INACTIVE INGREDIENT SECTION

croscarmellose sodium, FD&C red #40 aluminum lake, FD&C yellow #6 aluminum lake, hypromellose, lactose, magnesium stearate, microcrystalline cellulose, Opadry Clear YS-1-7006, polyethylene glycol, propylene glycol*, silicon dioxide, titanium dioxide. *May contain this ingredient

Questions or Comments?

INFORMATION FOR OWNERS/CAREGIVERS SECTION

Call 1-866-561-5650 Monday through Friday 9AM - 5PM

Box

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

Principal ImagePrincipal Image

Packet

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

PacketPacket

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYSPL version
1049182phenylephrine HCl 10 MG Oral TabletPSN2
1049182phenylephrine hydrochloride 10 MG Oral TabletSCD2

DailyMed Pharmacologic Classes#

Class, Version, Type table
ClassVersionTypeEffective
PHENYLEPHRINE Pharmacologic Class Indexing2Indexing - Pharmacologic Class20180813

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
e4e263da-1c53-440f-bb80-b7a575843b5aProduct name120260313
d2168cac-a261-415a-9c78-3522859fa720Product name320251124
05a8cdd1-eeb8-409e-b938-0778225eca7dProduct name420250221
e5b5c132-b15d-435b-9faa-2f74e5cadcf9Product name820250220
f489e8f3-5c9e-4818-b539-a73587edcfc7Product name220240229
0f7ae452-206d-4fc4-868d-56fc47074084Product name120231011
b5abe2e3-39a1-43eb-9bff-f3c1653fe3dfProduct name220190930
e0b6c8be-f2bd-9f86-a9fc-3ed56ffaa814Product name320150910
42f3c020-f1b3-89bc-7bdc-e1f10e680485Product name120140508
e949165d-714d-e548-2b76-0cb5def16f30Product name120140508

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
71105-272-01Redicare Nasal and Sinus Decongestant2 in 1 PACKETTABLET22
71105-272-02Redicare Nasal and Sinus Decongestant50 in 1 BOXTABLET502

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
71105-272REDICARE NASAL AND SINUS DECONGESTANT TABLET [REDICARE LLC]2Current NDC, 2 package rows20250306_2f24be68-f30e-d916-e063-6294a90a7e31.zip

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 14 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
71105-27271105-272-01, 71105-272-02

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 12 matching rows.

Source Document#

Source XML

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
Redicare Nasal and Sinus DecongestantREDICARE NASAL AND SINUS DECONGESTANTRedicare LLC2f24be68-f30e-d916-e063-6294a90a7e312025-03-04WarningsExact identifier
ndc (package): 71105-272-02
ndc (package): 71105-272-01
ndc (product): 71105-272
ndc11 (package): 71105027201
ndc11 (package): 71105027202
spl id: 2f85be59-0ea7-285b-e063-6294a90a2aa5
spl set id: 2f24be68-f30e-d916-e063-6294a90a7e31

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.